FDMT Operating Cash Flow (Statement)
4D Molecular Therapeutics Inc · Operating Cash Flow (Statement)
FDMT Operating Cash Flow (Statement)
Latest reported-$156.07Mperiod ending
FDMT Cash from Operations ($8.24M → -$156.07M)
Annual operating cash flow (statement)
High-resolution chart · PNG
FDMT operating cash flow (statement) history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -109,082,000 | |
| -134,585,000 | |
| -75,792,000 | |
| -86,685,000 | |
| -69,134,000 | |
| -50,909,000 | |
| -36,711,000 | |
| -16,252,000 | |
| 8,237,000 |